Cargando…
The N-terminal domain of Mycobacterium tuberculosis PPE17 (Rv1168c) protein plays a dominant role in inducing antibody responses in active TB patients
The PPE (proline-proline-glutamic acid) proteins of Mycobacterium tuberculosis are characterized by a conserved N-terminal domain of approximately 180 amino acids and variable C-terminal domain. Since last decade, these proteins have gained much importance in the serodiagnosis of tuberculosis (TB) a...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484515/ https://www.ncbi.nlm.nih.gov/pubmed/28651002 http://dx.doi.org/10.1371/journal.pone.0179965 |
_version_ | 1783245897215246336 |
---|---|
author | Abraham, Philip Raj Pathak, Niteen Pradhan, Gourango Sumanlatha, Gaddam Mukhopadhyay, Sangita |
author_facet | Abraham, Philip Raj Pathak, Niteen Pradhan, Gourango Sumanlatha, Gaddam Mukhopadhyay, Sangita |
author_sort | Abraham, Philip Raj |
collection | PubMed |
description | The PPE (proline-proline-glutamic acid) proteins of Mycobacterium tuberculosis are characterized by a conserved N-terminal domain of approximately 180 amino acids and variable C-terminal domain. Since last decade, these proteins have gained much importance in the serodiagnosis of tuberculosis (TB) as they act as a source of antigenic variation. We have demonstrated earlier that one of the PPE proteins PPE17 (Rv1168c) induces strong B-cell and T-cell responses in active TB disease and also displays a higher antibody titer compared to immunodominant antigens such as ESAT-6, Hsp60 and PPD. However, the immunodominant domain of PPE17 (N-terminal or C-terminal) was not examined in detail. In the present study, we observed that antibody responses elicited in TB patients were directed mostly towards the N-terminal domain of PPE17 (N-PPE17). The antibody generated against N-PPE17 in TB patients did not significantly cross-react with N-terminal domains of other PPE proteins used in this study. Our data suggest that the N-terminal domain of PPE17 protein is immunodominant and could be used as a better serodiagnostic marker than the full-length PPE17 protein. |
format | Online Article Text |
id | pubmed-5484515 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-54845152017-07-11 The N-terminal domain of Mycobacterium tuberculosis PPE17 (Rv1168c) protein plays a dominant role in inducing antibody responses in active TB patients Abraham, Philip Raj Pathak, Niteen Pradhan, Gourango Sumanlatha, Gaddam Mukhopadhyay, Sangita PLoS One Research Article The PPE (proline-proline-glutamic acid) proteins of Mycobacterium tuberculosis are characterized by a conserved N-terminal domain of approximately 180 amino acids and variable C-terminal domain. Since last decade, these proteins have gained much importance in the serodiagnosis of tuberculosis (TB) as they act as a source of antigenic variation. We have demonstrated earlier that one of the PPE proteins PPE17 (Rv1168c) induces strong B-cell and T-cell responses in active TB disease and also displays a higher antibody titer compared to immunodominant antigens such as ESAT-6, Hsp60 and PPD. However, the immunodominant domain of PPE17 (N-terminal or C-terminal) was not examined in detail. In the present study, we observed that antibody responses elicited in TB patients were directed mostly towards the N-terminal domain of PPE17 (N-PPE17). The antibody generated against N-PPE17 in TB patients did not significantly cross-react with N-terminal domains of other PPE proteins used in this study. Our data suggest that the N-terminal domain of PPE17 protein is immunodominant and could be used as a better serodiagnostic marker than the full-length PPE17 protein. Public Library of Science 2017-06-26 /pmc/articles/PMC5484515/ /pubmed/28651002 http://dx.doi.org/10.1371/journal.pone.0179965 Text en © 2017 Abraham et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Abraham, Philip Raj Pathak, Niteen Pradhan, Gourango Sumanlatha, Gaddam Mukhopadhyay, Sangita The N-terminal domain of Mycobacterium tuberculosis PPE17 (Rv1168c) protein plays a dominant role in inducing antibody responses in active TB patients |
title | The N-terminal domain of Mycobacterium tuberculosis PPE17 (Rv1168c) protein plays a dominant role in inducing antibody responses in active TB patients |
title_full | The N-terminal domain of Mycobacterium tuberculosis PPE17 (Rv1168c) protein plays a dominant role in inducing antibody responses in active TB patients |
title_fullStr | The N-terminal domain of Mycobacterium tuberculosis PPE17 (Rv1168c) protein plays a dominant role in inducing antibody responses in active TB patients |
title_full_unstemmed | The N-terminal domain of Mycobacterium tuberculosis PPE17 (Rv1168c) protein plays a dominant role in inducing antibody responses in active TB patients |
title_short | The N-terminal domain of Mycobacterium tuberculosis PPE17 (Rv1168c) protein plays a dominant role in inducing antibody responses in active TB patients |
title_sort | n-terminal domain of mycobacterium tuberculosis ppe17 (rv1168c) protein plays a dominant role in inducing antibody responses in active tb patients |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484515/ https://www.ncbi.nlm.nih.gov/pubmed/28651002 http://dx.doi.org/10.1371/journal.pone.0179965 |
work_keys_str_mv | AT abrahamphilipraj thenterminaldomainofmycobacteriumtuberculosisppe17rv1168cproteinplaysadominantroleininducingantibodyresponsesinactivetbpatients AT pathakniteen thenterminaldomainofmycobacteriumtuberculosisppe17rv1168cproteinplaysadominantroleininducingantibodyresponsesinactivetbpatients AT pradhangourango thenterminaldomainofmycobacteriumtuberculosisppe17rv1168cproteinplaysadominantroleininducingantibodyresponsesinactivetbpatients AT sumanlathagaddam thenterminaldomainofmycobacteriumtuberculosisppe17rv1168cproteinplaysadominantroleininducingantibodyresponsesinactivetbpatients AT mukhopadhyaysangita thenterminaldomainofmycobacteriumtuberculosisppe17rv1168cproteinplaysadominantroleininducingantibodyresponsesinactivetbpatients AT abrahamphilipraj nterminaldomainofmycobacteriumtuberculosisppe17rv1168cproteinplaysadominantroleininducingantibodyresponsesinactivetbpatients AT pathakniteen nterminaldomainofmycobacteriumtuberculosisppe17rv1168cproteinplaysadominantroleininducingantibodyresponsesinactivetbpatients AT pradhangourango nterminaldomainofmycobacteriumtuberculosisppe17rv1168cproteinplaysadominantroleininducingantibodyresponsesinactivetbpatients AT sumanlathagaddam nterminaldomainofmycobacteriumtuberculosisppe17rv1168cproteinplaysadominantroleininducingantibodyresponsesinactivetbpatients AT mukhopadhyaysangita nterminaldomainofmycobacteriumtuberculosisppe17rv1168cproteinplaysadominantroleininducingantibodyresponsesinactivetbpatients |